Hepatitis B and hepatitis C are both serious viral infections affecting the liver, but they are caused by different viruses and spread in distinct ways. Understanding how these two conditions differ is crucial for getting timely diagnosis and appropriate treatment. This guide explains the key differences, how each spreads, their symptoms, and the treatment options available to manage them effectively.
What are the main differences between hepatitis B and C?
Hepatitis B and hepatitis C are caused by two separate viruses, the hepatitis B virus (HBV) and the hepatitis C virus (HCV), and they affect your liver in distinct ways. While both are chronic conditions that can damage liver tissue over time, their progression, severity, and treatment response differ significantly. Hepatitis B is more common globally, with around 296 million people living with chronic infection, whereas hepatitis C affects approximately 58 million people worldwide. The main distinction lies in how these viruses behave: HBV can cause lifelong infection in adults but the immune system often clears it naturally, whereas HCV almost always leads to chronic infection if left untreated. Your body's response to each virus also varies, some people develop serious complications like cirrhosis or liver cancer from hepatitis B, while others may carry the virus without severe symptoms for decades. Recognizing these differences helps your doctor tailor treatment specifically to your infection type.
How do hepatitis B and C spread differently?
Hepatitis B and C spread through different routes, which shapes how you may have become infected and who around you might be at risk. Hepatitis B spreads primarily through contact with infected blood or body fluids, including unprotected sexual contact, sharing of contaminated needles, or from mother to child during birth. Healthcare workers and people who inject drugs face higher risk. Hepatitis C, conversely, spreads almost exclusively through blood-to-blood contact, particularly via needle sharing, blood transfusions before 1992 (when screening became routine), or occupational needlestick injuries. Sexual transmission of hepatitis C is rare unless there is a break in mucous membranes. Neither virus spreads through casual contact, shared food, hugging, or respiratory droplets. Knowing the transmission route helps you understand your infection's source and what preventive measures are needed to protect others. If you were infected through injection drug use, your treatment journey may include additional support services alongside medical care.
What are the symptoms of each infection?
Many people with hepatitis B or C have no obvious symptoms, especially in the early stages, which is why routine testing matters even if you feel well. When symptoms do appear, they often feel similar for both infections, including fatigue, abdominal pain, jaundice (yellowing of skin and eyes), dark urine, and pale stools. However, the timing and severity differ. Acute hepatitis B (recent infection) typically causes symptoms within 45-180 days, though some people remain asymptomatic. Acute hepatitis C often causes no symptoms at all, and people may not realize they are infected for years. Chronic hepatitis B and C develop silently; you may have active liver damage without feeling unwell. This silent progression is why screening is vital, particularly if you have risk factors like a history of injection drug use, multiple sexual partners, or occupational exposure to blood. The absence of symptoms does not mean the infection is harmless, both viruses can cause cirrhosis and liver cancer over time. If you experience persistent fatigue, unexplained abdominal pain, or yellowing of the skin, consult a specialist promptly.
How are hepatitis B and C diagnosed?
Diagnosis begins with a blood test that detects antibodies or antigens specific to each virus. For hepatitis B, initial screening looks for the hepatitis B surface antigen (HBsAg), which signals active infection. If positive, further tests measure HBeAg (e-antigen) and viral load, the amount of virus in your blood, to determine how active the infection is and whether you need treatment. Your doctor may also order liver function tests to assess how well your liver is working. For hepatitis C, an initial antibody test shows past or current exposure to the virus. A positive antibody result must be confirmed with an HCV RNA test, which detects active viral replication. If HCV RNA is present, your doctor will identify the virus genotype (strain), as treatment choice depends on which genotype you have. Ultrasound or specialized imaging may be recommended to check your liver for scarring or signs of advanced disease. Testing is painless and straightforward, typically completed within days. Early diagnosis allows treatment before serious complications develop, which is why screening is especially important if you have risk factors or unexplained liver symptoms.
Treatment approaches for hepatitis B and hepatitis C
Treatment strategies differ markedly between hepatitis B and C because the viruses respond to different classes of antiviral medications. Hepatitis B is managed with antivirals like nucleoside reverse transcriptase inhibitors (NRTIs) or nucleotide reverse transcriptase inhibitors (NtRTIs), which slow viral replication and reduce inflammation in your liver. These medications are taken daily, often for many years or indefinitely, to keep the virus suppressed and prevent progression to cirrhosis or liver cancer. The goal is viral suppression rather than cure, most people with chronic hepatitis B remain on lifelong therapy. Hepatitis C, by contrast, is often curable with direct-acting antivirals (DAAs), a newer class of drugs that target specific viral proteins. A typical course of DAA therapy lasts 8-12 weeks and achieves sustained virological response (SVR), meaning no detectable virus, in 95% or more of treated patients. This represents a major breakthrough; hepatitis C is now considered curable in most cases when diagnosed and treated early. Your treatment plan depends on your viral load, liver health, genotype (for hepatitis C), and any other health conditions you have. Regular monitoring ensures your treatment is working and allows your doctor to adjust your plan if needed.
Why Patients From Across India and Abroad Choose Rameswara Nursing Home for Liver Health
If you've been putting off getting tested because you're worried about cost, or you're trying to figure out where a family member back home can get reliable liver care, here's the honest picture:
Rameswara Nursing Home has spent more than 35 years building exactly this kind of trust in Kolkata. It is NABH-accredited, independently assessed against national patient-safety and quality benchmarks, not just a claim on a website, and it runs as a 50-bed, multi-specialty hospital with 80-plus consultants across departments including Gastroenterology, Urology & Nephrology, General Surgery, and more.
For hepatitis screening specifically, that scale matters. You're not being sent to three different labs and two different specialists before someone puts the full picture together, blood work, imaging, and a gastroenterologist's opinion can typically happen in the same building, often the same day.
The hospital's location at P-155, C.I.T. Scheme VII-M, Ultadanga, near P.C. Chandra (HUDCO More), is easy to reach from most parts of Kolkata and neighbouring districts, and its cashless insurance and TPA tie-ups mean the cost conversation doesn't have to happen after the fact.
For patients travelling from other states or from abroad, a growing number of NRI and international patients come to Kolkata specifically because Indian generic hepatitis C treatment costs a fraction of Western pricing, Rameswara Nursing Home's team can coordinate testing, treatment planning, and follow-up visits around a realistic travel schedule. It isn't about being the flashiest hospital in the country; it's about getting a correct diagnosis quickly and making the treatment that follows affordable enough that people actually complete it, which, for hepatitis B and C, is the difference that matters most.
Conclusion
Hepatitis B and hepatitis C both attack the liver, but they are not interchangeable diagnoses. Hepatitis B is vaccine-preventable and, for most adults, self-limiting, though it can become a lifelong condition needing long-term antiviral management. Hepatitis C has no vaccine but is curable in the vast majority of cases with a short course of modern antivirals, one of the genuine success stories in infectious disease medicine over the past decade. What connects them is that both are frequently silent until real liver damage has occurred, which is exactly why a simple blood test, done early, makes such a disproportionate difference to the outcome.
If you have any risk factors, a blood transfusion before rigorous screening protocols, shared needles, an infected family member, or simply haven't been screened before, getting a hepatitis B and C panel done is a low-cost, low-effort step that closes off years of uncertainty. Rameswara Nursing Home's Gastroenterology team in Ultadanga, Kolkata, offers this screening and the follow-up care pathway under one roof for patients from Kolkata, across India, and abroad.
Chat with our medical assistant today for instant guidance, or to book a Gastroenterology consultation at our Ultadanga, Kolkata facility.
_Medical Disclaimer: This article is for general informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Hepatitis B and C require confirmed laboratory diagnosis and individualised care from a qualified physician. Always consult a licensed doctor, hepatologist, or gastroenterologist regarding any questions about your health, symptoms, or treatment options. Rameswara Nursing Home does not provide medical advice through this content, please book a consultation for a personal assessment. _
